Ketoosin
Ketoosin is a monoclonal antibody used in the treatment of acute myocardial infarction and unstable angina. It is designed to inhibit platelet aggregation, reducing the risk of thrombosis and subsequent heart attack or stroke.
In clinical trials, ketoosin has been shown to be effective in reducing the risk of recurrent ischemic
Ketoosin was approved for use in the treatment of acute coronary syndrome by regulatory agencies in several
Common side effects of ketoosin include bleeding, thrombocytopenia, and anaphylaxis. Patients who experience any of these
Ketoosin is typically administered via intravenous infusion over a period of several hours or days. The exact
Ketoosin is not approved for use in patients with bleeding disorders or those who are taking anticoagulant